107 related articles for article (PubMed ID: 24926634)
1. [New frequent adverse reaction of PPI in older adults: mild hyponatremia].
Peyro Saint Paul L; Martin J; Buon M; Gaillard C; Fedrizzi S; Mosquet B; Coquerel A
Therapie; 2014; 69(2):157-62. PubMed ID: 24926634
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Paul LP; Martin J; Buon M; Gaillard C; Fedrizzi S; Mosquet B; Coquerel A
Therapie; 2014; 69(2):157-62. PubMed ID: 27392707
[TBL] [Abstract][Full Text] [Related]
3. Risk of proton pump inhibitor-induced mild hyponatremia in older adults.
Buon M; Gaillard C; Martin J; Fedrizzi S; Mosquet B; Coquerel A; Peyro Saint Paul L
J Am Geriatr Soc; 2013 Nov; 61(11):2052-4. PubMed ID: 24219214
[No Abstract] [Full Text] [Related]
4. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium.
Bebarta VS; King JA; McDonough M
Am J Emerg Med; 2008 May; 26(4):519.e1-2. PubMed ID: 18410837
[TBL] [Abstract][Full Text] [Related]
6. Uses of proton pump inhibitors and serum potassium levels.
Gau JT; Heh V; Acharya U; Yang YX; Kao TC
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):865-71. PubMed ID: 19557730
[TBL] [Abstract][Full Text] [Related]
7. [Proton-pump inhibitor use and hyponatremia].
Goto M; Sakai M
Nihon Ronen Igakkai Zasshi; 2023; 60(2):153-157. PubMed ID: 37225507
[TBL] [Abstract][Full Text] [Related]
8. Considerations for the use of proton-pump inhibitors in older adults.
Desilets AR; Asal NJ; Dunican KC
Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous reactions to proton pump inhibitors: a case-control study.
Chularojanamontri L; Jiamton S; Manapajon A; Suvanasuthi S; Kulthanan K; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2012 Oct; 11(10):e43-7. PubMed ID: 23134998
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor use and the antifracture efficacy of alendronate.
Abrahamsen B; Eiken P; Eastell R
Arch Intern Med; 2011 Jun; 171(11):998-1004. PubMed ID: 21321287
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study.
Mannesse CK; Jansen PA; Van Marum RJ; Sival RC; Kok RM; Haffmans PM; Egberts TC
Maturitas; 2013 Dec; 76(4):357-63. PubMed ID: 24094459
[TBL] [Abstract][Full Text] [Related]
13. Thiazide-associated hyponatremia: a population-based study.
Rodenburg EM; Hoorn EJ; Ruiter R; Lous JJ; Hofman A; Uitterlinden AG; Stricker BH; Visser LE
Am J Kidney Dis; 2013 Jul; 62(1):67-72. PubMed ID: 23602191
[TBL] [Abstract][Full Text] [Related]
14. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
[TBL] [Abstract][Full Text] [Related]
15. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
16. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
[TBL] [Abstract][Full Text] [Related]
17. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
[TBL] [Abstract][Full Text] [Related]
18. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia.
Issa I; Skov J; Falhammar H; Calissendorff J; Lindh JD; Mannheimer B
Eur J Clin Pharmacol; 2023 Jan; 79(1):71-77. PubMed ID: 36380227
[TBL] [Abstract][Full Text] [Related]
20. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
